series-c-plus
Stage
2018
Founded
2
Investors
About
ALX Oncology is a clinical-stage immuno-oncology company focused on developing therapies that block the CD47 checkpoint pathway to help patients fight cancer.
Explore ALX Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.